Rottapharm Biotech will continue to leverage its long-standing expertise in medicinal and computational chemistry, which has allowed the design and synthesis of
- more than 10000 original compounds and
- 19 new drugs on the market.
They are covered by
- more than 500 patents
- belonging to nearly 80 patent families
and are described in
- over 1000 peer-reviewed scientific publications.
The synthesis internal capability ranges between milligrams and grams, in order to meet in vitro and in vivo preclinical testing needs. Experienced scientists are then devoted to manage third-party scale-up activities to meet the needs of clinical development.
Medicinal chemistry programs take also advantage of a high-throughput screening (HTS) library for fast screening on different targets.